{
    "2021-08-26": [
        [
            {
                "time": "2021-08-26",
                "original_text": "泰格医药：扣非持续亮眼 新签订单大幅增长 主业加速恢复",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "新签订单",
                        "大幅增长",
                        "主业恢复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "泰格医药2021年中报点评：21H1国际业务占比持续提升 在手订单金额增长超出预期",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "中报",
                        "国际业务",
                        "订单增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "订单量增长25%！中期营收超预期，“投资+CRO”双轮驱动下，泰格医药“项庄舞剑意在沛公”",
                "features": {
                    "keywords": [
                        "订单量增长",
                        "营收超预期",
                        "投资+CRO",
                        "泰格医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "泰格医药2021年上半年营收20.56亿元 同比增长41.62%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "营收增长",
                        "上半年"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "跌出价值！千亿白马频现回购，强护盘模式开启",
                "features": {
                    "keywords": [
                        "跌出价值",
                        "回购",
                        "护盘"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "泰格医药亮业绩 股价跌4.8% 上半年ROE毛利率均降 盈利能力下降",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "股价下跌",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "【异动股】泰格医药(03347.HK)跌3.08%",
                "features": {
                    "keywords": [
                        "异动股",
                        "泰格医药",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "【AH互动】泰格医药(03347)中期纯利同比增25.65% H股涨3.8%",
                "features": {
                    "keywords": [
                        "AH互动",
                        "泰格医药",
                        "中期纯利增长",
                        "H股上涨"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "港股异动︱泰格医药(03347)涨超6% 中期归母净利同比增长25.65%至12.55亿元",
                "features": {
                    "keywords": [
                        "港股异动",
                        "泰格医药",
                        "归母净利增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "港股异动 | 泰格医药(3347.HK)涨5.68% 上半年净利升25.65%至12.55亿元",
                "features": {
                    "keywords": [
                        "港股异动",
                        "泰格医药",
                        "净利上升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}